Search research articles
Contact Us
Filters
Showing results (241-250 of 274) with videos related to
Page
of 28
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice
|
October 13, 2023
Tobacco Exposure and Efficacy of Biologic Therapy in Patients With Severe Asthma: A Nationwide Study From the Danish Severe Asthma Register
Marianne Baastrup Soendergaard, Susanne Hansen, Anne-Sofie Bjerrum, et al.
ERJ Open Research
|
March 18, 2026
Cumulative corticosteroid burden over 25 years in patients initiating biologic therapy for severe asthma: a nationwide cohort study
Galathea Berner, Marianne Baastrup Soendergaard, Susanne Hansen, et al.
Chest
|
November 4, 2023
Clinical Response and Remission in Patients With Severe Asthma Treated With Biologic Therapies
Susanne Hansen, Marianne Baastrup Søndergaard, Anna von Bülow, et al.
Acta Anaesthesiologica Scandinavica
|
April 11, 2022
Senicapoc treatment in COVID-19 patients with severe respiratory insufficiency-A randomized, open-label, phase II trial
Asger Granfeldt, Lars W Andersen, Mikael F Vallentin, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
April 5, 2026
Five-year inhaled, systemic and total corticosteroid exposure reduction during anti-Interleukin-5/Rα treatment for severe asthma
Kjell Erik Julius Håkansson, Susanne Hansen, Marianne Baastrup Soendergaard, et al.
ERJ Open Research
|
January 27, 2022
Epidemiology of interstitial lung diseases and their progressive-fibrosing behaviour in six European countries
Ole Hilberg, Anna-Maria Hoffmann-Vold, Vanessa Smith, et al.
Clinical Biochemistry
|
June 21, 2023
A serologically assessed neo-epitope biomarker of cellular fibronectin degradation is related to pulmonary fibrosis
Annika Hummersgaard Hansen, Helene Wallem Breisnes, Thomas Skovhus Prior, et al.
Allergy
|
December 14, 2024
Early Reduction of FeNO on Anti-IL5 Biologics Is Associated With Clinical Remission of Severe Asthma
Marianne Baastrup Soendergaard, Susanne Hansen, Kjell Erik Julius Håkansson, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
July 15, 2025
Biologic Prescription Patterns and Biomarker Determinants of First-Line Dupilumab in Danish Adult Patients With Severe Asthma and Comorbid Atopic Dermatitis
Marianne Baastrup Soendergaard, Kjell Erik Julius Håkansson, Susanne Hansen, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
September 13, 2025
Tezepelumab in Real-Life Practice: Characteristics of Patients Commenced and Efficacy in a Nationwide, Danish Cohort of Patients With Severe Asthma
Marianne Baastrup Soendergaard, Kjell Erik Julius Haakansson, Susanne Hansen, et al.
Page
of 28
Search research articles
Search
Showing results (241-250 of 274) with videos related to
Sort By:
Page
of 28
The Journal of Allergy and Clinical Immunology. in Practice
|
October 13, 2023
Tobacco Exposure and Efficacy of Biologic Therapy in Patients With Severe Asthma: A Nationwide Study From the Danish Severe Asthma Register
Marianne Baastrup Soendergaard, Susanne Hansen, Anne-Sofie Bjerrum, et al.
ERJ Open Research
|
March 18, 2026
Cumulative corticosteroid burden over 25 years in patients initiating biologic therapy for severe asthma: a nationwide cohort study
Galathea Berner, Marianne Baastrup Soendergaard, Susanne Hansen, et al.
Chest
|
November 4, 2023
Clinical Response and Remission in Patients With Severe Asthma Treated With Biologic Therapies
Susanne Hansen, Marianne Baastrup Søndergaard, Anna von Bülow, et al.
Acta Anaesthesiologica Scandinavica
|
April 11, 2022
Senicapoc treatment in COVID-19 patients with severe respiratory insufficiency-A randomized, open-label, phase II trial
Asger Granfeldt, Lars W Andersen, Mikael F Vallentin, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
April 5, 2026
Five-year inhaled, systemic and total corticosteroid exposure reduction during anti-Interleukin-5/Rα treatment for severe asthma
Kjell Erik Julius Håkansson, Susanne Hansen, Marianne Baastrup Soendergaard, et al.
ERJ Open Research
|
January 27, 2022
Epidemiology of interstitial lung diseases and their progressive-fibrosing behaviour in six European countries
Ole Hilberg, Anna-Maria Hoffmann-Vold, Vanessa Smith, et al.
Clinical Biochemistry
|
June 21, 2023
A serologically assessed neo-epitope biomarker of cellular fibronectin degradation is related to pulmonary fibrosis
Annika Hummersgaard Hansen, Helene Wallem Breisnes, Thomas Skovhus Prior, et al.
Allergy
|
December 14, 2024
Early Reduction of FeNO on Anti-IL5 Biologics Is Associated With Clinical Remission of Severe Asthma
Marianne Baastrup Soendergaard, Susanne Hansen, Kjell Erik Julius Håkansson, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
July 15, 2025
Biologic Prescription Patterns and Biomarker Determinants of First-Line Dupilumab in Danish Adult Patients With Severe Asthma and Comorbid Atopic Dermatitis
Marianne Baastrup Soendergaard, Kjell Erik Julius Håkansson, Susanne Hansen, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
September 13, 2025
Tezepelumab in Real-Life Practice: Characteristics of Patients Commenced and Efficacy in a Nationwide, Danish Cohort of Patients With Severe Asthma
Marianne Baastrup Soendergaard, Kjell Erik Julius Haakansson, Susanne Hansen, et al.
Page
of 28